Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Axogen Inc (AXGN)

Axogen Inc (AXGN)
15.99 -0.77 (-4.59%) 13:05 ET [NASDAQ]
15.86 x 100 15.99 x 100
Realtime by (Cboe BZX)
15.86 x 100 15.99 x 100
Realtime 16.55 -0.21 (-1.25%) 04:22 ET
Quote Overview for Thu, Apr 10th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
15.75
Day High
16.66
Open 16.66
Previous Close 16.76 16.76
Volume 79,386 79,386
Avg Vol 532,500 532,500
Stochastic %K 21.40% 21.40%
Weighted Alpha +78.57 +78.57
5-Day Change -1.24 (-7.28%) -1.24 (-7.28%)
52-Week Range 5.55 - 21.00 5.55 - 21.00
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 743,206
  • Shares Outstanding, K 44,344
  • Annual Sales, $ 187,340 K
  • Annual Income, $ -9,960 K
  • EBIT $ -3 M
  • EBITDA $ 5 M
  • 60-Month Beta 1.00
  • Price/Sales 3.77
  • Price/Cash Flow N/A
  • Price/Book 6.74

Options Overview Details

View History
  • Implied Volatility 107.89% ( +29.46%)
  • Historical Volatility 48.41%
  • IV Percentile 84%
  • IV Rank 47.26%
  • IV High 215.06% on 05/02/24
  • IV Low 11.85% on 08/13/24
  • Put/Call Vol Ratio 1.00
  • Today's Volume 6
  • Volume Avg (30-Day) 79
  • Put/Call OI Ratio 0.62
  • Today's Open Interest 2,586
  • Open Int (30-Day) 2,393

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.09
  • Number of Estimates 3
  • High Estimate -0.07
  • Low Estimate -0.13
  • Prior Year -0.15
  • Growth Rate Est. (year over year) +40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.26 +3.54%
on 04/07/25
Period Open: 17.17
19.45 -18.77%
on 03/26/25
-1.37 (-7.98%)
since 03/10/25
3-Month
15.26 +3.54%
on 04/07/25
Period Open: 18.05
21.00 -24.76%
on 02/25/25
-2.25 (-12.47%)
since 01/10/25
52-Week
5.55 +184.68%
on 05/06/24
Period Open: 7.50
21.00 -24.76%
on 02/25/25
+8.30 (+110.67%)
since 04/10/24

Most Recent Stories

More News
Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

AXGN : 15.99 (-4.59%)
AxoGen: Q4 Earnings Snapshot

AxoGen: Q4 Earnings Snapshot

AXGN : 15.99 (-4.59%)
Axogen, Inc. To Host Analyst & Investor Day on March 4th

AXGN : 15.99 (-4.59%)
Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results

AXGN : 15.99 (-4.59%)
Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025

AXGN : 15.99 (-4.59%)
Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

AXGN : 15.99 (-4.59%)
Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

AXGN : 15.99 (-4.59%)
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024

AXGN : 15.99 (-4.59%)
Here's Why you Should Retain Nevro Stock in Your Portfolio Now

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its technological innovations and diversification plans regarding its product portfolio. The optimism, led by a solid third-quarter...

AXGN : 15.99 (-4.59%)
NVRO : 5.84 (unch)
ARAY : 1.4750 (-7.23%)
MASI : 152.88 (-7.10%)
Here's Why You Should Add Glaukos Stock to Your Portfolio Now

Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial results and a robust product pipeline. However, stiff competition is a concern.Shares of this Zacks Rank #2 (Buy)...

AXGN : 15.99 (-4.59%)
ARAY : 1.4750 (-7.23%)
MASI : 152.88 (-7.10%)
GKOS : 88.90 (-4.97%)

Business Summary

AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch...

See More

Key Turning Points

3rd Resistance Point 19.34
2nd Resistance Point 18.25
1st Resistance Point 17.51
Last Price 15.99
1st Support Level 15.68
2nd Support Level 14.59
3rd Support Level 13.85

See More

52-Week High 21.00
Last Price 15.99
Fibonacci 61.8% 15.10
Fibonacci 50% 13.27
Fibonacci 38.2% 11.45
52-Week Low 5.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar